Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis
In conclusion, our study presents ezetimibe as a potential novel therapeutic for idiopathic pulmonary fibrosis.PMID:38359963 | DOI:10.1183/13993003.00580-2023
Source: Respiratory Care - Category: Respiratory Medicine Authors: Chanho Lee Se Hyun Hyun Jisu Han Ju Hye Shin Byunghun Yoo Yu Seol Lee Jeong Su Park Beom Jin Lim Jin Gu Lee Young Sam Kim Song Yee Kim Soo Han Bae Source Type: research
More News: Cholesterol | European Medicines Agency (EMA) | Genetics | Niemann-Pick Disease | Respiratory Medicine | Study | Vytorin | Zetia